Establishment Labs to Participate in Two Upcoming Investment Conferences

Rhea-AI Summary

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focusing on women’s health in breast aesthetics and reconstruction, announced participation in two investment conferences. CEO Juan José Chacón-Quirós and CFO Renee Gaeta will present at the Jefferies Virtual London Healthcare Conference from November 17-19, 2020, and at the Stephens Virtual Investment Conference from November 16-20, 2020. Presentations will be webcast live on their investor relations website, with archived versions available post-event.

SANTA BARBARA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its participation in two investment conferences this month.

Chief Executive Officer and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the 2020 Jefferies Virtual London Healthcare Conference being held on November 17-19, 2020. Mr. Chacón-Quirós and Ms. Gaeta are scheduled to speak to conference attendees at 2:55 pm ET on Tuesday, November 17, 2020.

Mr. Chacón-Quirós and Ms. Gaeta will also participate in the Stephens Virtual Investment Conference 2020 being held on November 16-20, 2020. Mr. Chacón-Quirós and Ms. Gaeta are scheduled to speak to conference attendees at 2:00 pm ET on Thursday, November 19, 2020.

A live webcast of these presentations will be available to all interested parties on the Establishment Labs investor relations website at https://investors.establishmentlabs.com/. An archived version of the webcasts will be available on the same website following the completion of each event.

About Establishment Labs
Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a global medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at our two manufacturing sites that are compliant with ISO13485:2016, FDA 21 CFR 820 under the MDSAP program, and are currently commercially available in more than 80 countries through exclusive distributors or the Company’s direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA and initiated the Motiva Implant® clinical trial in the United States in April 2018. In addition to Motiva Implants®, Establishment Labs’ product and technologies portfolio includes the Divina® 3D Simulation System and other products and services. Please visit our website for additional information at www.establishmentlabs.com.

Investor/Media Contact:
David K. Erickson
949-447-6671
derickson@establishmentlabs.com

FAQ

When is Establishment Labs participating in investment conferences?

Establishment Labs will participate in the Jefferies Virtual London Healthcare Conference from November 17-19, 2020, and the Stephens Virtual Investment Conference from November 16-20, 2020.

What time will Establishment Labs present at the Jefferies conference?

Establishment Labs will present at the Jefferies Virtual London Healthcare Conference on November 17, 2020, at 2:55 pm ET.

When will Establishment Labs present at the Stephens conference?

Establishment Labs will present at the Stephens Virtual Investment Conference on November 19, 2020, at 2:00 pm ET.

Where can I watch the presentations of Establishment Labs?

The presentations of Establishment Labs will be available via live webcast on their investor relations website and archived following each event.

What is the focus of Establishment Labs?

Establishment Labs focuses on women's health, specifically in breast aesthetics and reconstruction, offering products like Motiva Implants®.